LAMP2 and myeloid sarcoma: An interesting study evaluating the urine samples of pregnant women identified changes in two proteins (trefoil factor 3 and lysosomal associated membrane protein 2) to not only discriminate between the third trimester and the postpartum period, but also between MS patients and the control group [153].